The reported clinical features of ALS associated with TBK1 mutations are variable in the age of onset, progression of the disease, survival duration, and presence of cognitive impairment and extrapyramidal symptoms (Van Mossevelde et al., 2016). The gene discussed is TBK1; the disease is amyotrophic lateral sclerosis.